Hycamtin topotecan hydrochloride regulatory update

FDA approved an sNDA for Hycamtin for use with cisplatin to treat stage IVB recurrent or persistent carcinoma of the cervix that cannot be treated with surgery and/or radiation therapy. The topoisome...